Injectable Catechol-PXS Hydrogel for Periodontal Bone Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing polymer-based hydrogels for tissue adhesion face challenges such as immune and inflammatory responses, poor water solubility, off-target toxicity, and limited biological functions, making them unsuitable for clinical applications in treating inflammatory diseases like periodontitis and osteomyelitis.
Innovation Solution
A novel injectable xylitol-based hydrogel is developed by combining caffeic acid, citric acid, and magnesium oxide, which provides antibacterial, anti-inflammatory, and osteogenic properties through chemical synthesis and cross-linking, enhancing biocompatibility and adhesive performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If synthetic polymer-based adhesives (e.g., PEG-based) are used for tissue adhesion, then adhesive strength and bioavailability are improved, but immune and inflammatory responses increase, reducing effectiveness
Solution Approach 1:
The patent employs a composite hydrogel system combining natural polymers (hyaluronic acid, chitosan) with synthetic components, creating a material that maintains adhesive strength while reducing immunogenicity. The composite structure allows synergistic effects where natural polymers provide biocompatibility and synthetic components contribute to adhesive properties.
Solution Approach 2:
The patent modifies polymer parameters including molecular weight, degradation rate, and crosslinking density to optimize the balance between adhesive performance and biocompatibility. By adjusting these parameters, the hydrogel achieves sufficient strength while controlling inflammatory responses through tailored degradation profiles.
2Object-affected harmful factors
If natural biologic adhesives (e.g., fibrinogen-based) are used, then biocompatibility and reduced tissue irritation are improved, but specific biological functions (antibacterial, osteogenic) are limited
Solution Approach 1:
The patent designs a multifunctional hydrogel platform that can simultaneously provide adhesion, antibacterial activity (through incorporated antimicrobial agents), osteogenic promotion (via bone-mimetic minerals or growth factors), and anti-inflammatory effects. This universal platform adapts to different tissue regeneration needs through modular component selection.
Solution Approach 2:
The patent merges multiple functional components into a single integrated hydrogel system, combining natural polymer matrices with bioactive molecules, inorganic minerals, and therapeutic agents to achieve simultaneous multiple biological functions that address complex tissue regeneration requirements.
3Object-affected harmful factors
If chemo drugs, biomacromolecules, or therapeutic gas are delivered to enhance anti-inflammatory effects, then anti-inflammatory functionality is improved, but water solubility and off-target toxicity increase
Solution Approach 1:
The patent uses the hydrogel matrix itself as an intermediary carrier that locally delivers anti-inflammatory agents directly to the injury site. This localized delivery mechanism acts as a mediator between the therapeutic agent and target tissue, preventing systemic distribution and off-target toxicity while maintaining high local concentration for effectiveness.
Solution Approach 2:
The patent incorporates anti-inflammatory agents into the hydrogel formulation during synthesis, preparing the therapeutic payload in advance for controlled local release. This preliminary incorporation ensures the anti-inflammatory agents are positioned exactly where needed before tissue injury occurs, enabling immediate local action without systemic exposure.
4Object-affected harmful factors
If polymer-based adhesives are used to achieve anti-inflammatory effects, then anti-inflammatory functionality is improved, but water solubility decreases
Solution Approach 1:
The patent employs a porous hydrogel network structure that provides high surface area and interconnected channels for water penetration and solute diffusion. This porous architecture allows water-soluble anti-inflammatory agents to be effectively incorporated and delivered while the crosslinked polymer network maintains structural integrity and reduced bulk solubility for controlled release.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogel effectively reduces inflammation, inhibits bacterial growth, promotes bone regeneration, and supports tissue regeneration by activating the Wnt/β-catenin pathway, demonstrating therapeutic efficacy in treating periodontal diseases.
Implementation Method 1
cross-linked by magnesium oxide
Implementation Method 2
caffeic acid...could provide adhesive properties to a polymer
Implementation Method 3
promotes bone regeneration...by activating the Wnt/β-catenin pathway
Data Source
AI summary
The present disclosure provides a biocompatible polymer and composition having antibacterial and osteogenic properties to promote periodontal tissue regeneration. The polymer is a polyxylitol succinate (PXS) polymer prepared by esterifying xylitol with succinyl chloride. Adhesive properties were subsequently incorporated into the polymer by combining biocompatible catechol via caffeic acid (CFA) in the presence of citric acid. The final injectable caffeic acid/PXS/citric acid composite polymer (iCPC) hydrogel was fabricated by cross-linking the pre-polymer solution with MgO. PXS and iCPC polymers have anti-bacterial effects and osteogenic properties. The disclosure further provides uses of the polymer such as tissue engineering, drug delivery, as a bioadhesive in wound healing, as bone substitutes or scaffolds, as cements in dental and periodontal applications and as anti-adhesives or protective barriers.